COJOCARU, S. .; RUSSU, I. .; BUTA, G. .; BERSAN, S.; POTÎNG-RAȘCOV, V.; CULIUC, N.; BABA, L. A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. One Health & Risk Management , [S. l.], v. 4, n. 4, p. 19–26, 2023. DOI: 10.38045/ohrm.2023.4.02. Disponível em: https://ojs.incomoza.md/index.php/journal-ohrm-bba-md/article/view/374. Acesso em: 17 sep. 2026.